MentionFox
Sutrix helps hospital clinical research teams accelerate studies by eliminating manual data preparation. We deploy software into their existing systems, transforming data from EHRs, wearables, and other external sources into validated, study-ready datasets.
Sell to companies like these? Paste your website and see 10 with a filed reason to buy this month. Free.
Opens in a new tab. No signup.
New accelerator entry · 2026-10-12 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Sutrix.
Free to see. No signup.
We'll show it in your MentionFox inbox when Sutrix raises, hires or launches. No email unless you switch it on.
Watch Sutrix →Get the full cited report on Sutrix
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Sutrix: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Sutrix helps hospital clinical research teams accelerate studies by eliminating manual data preparation. We deploy software into their existing systems, transforming data from EHRs, wearables, and other external sources into validated, study-ready datasets. Our software applies study-specific definitions, reconciles conflicting records, and flags unresolved cases for review, reducing repetitive manual work across research workflows.
Checked away from the directory entry. What is below does not come from the company's Y Combinator page.
Sutrix deploys integrated analysis systems that enable biostatistics cores dealing with large, fragmented, messy data to deliver publishable results in days, tripling study capacity.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
B.S. Neuroscience, Georgia Tech. Published clinical researcher at Hospital for Special Surgery, Emory, and Georgia Tech. Built a multi-sport injury surveillance system at HSS now running across 700+ teams and 30+ tournaments. Led a 300-participant IRB-approved concussion study at GT and prepared a VR concussion assessment tool for FDA 510(k) submission.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Sutrix: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Sutrix covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist SutrixYou get an alert in MentionFox the next time this company shows up.
If you're behind Sutrix: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry, and from the company's own site, read directly on 2026-10-13 (sutrix.ai).
Each opens in a new tab, filled in for Sutrix. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/yc-sutrix